|
|
Pro-Cure's USP
- Pro-Cure is a world leader in the culture, isolation, handling and analysis of human cancer stem cells (CSCs) with initial focus on prostate derived CSCs
- In contrast to some groups providing CSCs with questionable authenticity, it has developed a robust protocol for isolating pure CSC preparations – a world-leading resource for cancer drug discovery and evaluation.
- Excellent relationships with major cancer centres allowing a steady flow of human primary tissue.
- Has proprietary in vitro assays and is developing in vivo assays that underpin the Company’s drug discovery engine.
- Developing a rapidly growing catalogue of therapeutic cancer targets and amassing valuable IP on prioritised targets
- Significant in-house expertise in biology, pathology and molecular therapies.
|
|
|
